Author:
Zheng Wen,Gao Yuhuan,Ke Xiaoyan,Zhang Weijing,Su Liping,Ren Hanyun,Lin Ningjing,Xie Yan,Tu Meifeng,Liu Weiping,Ping Lingyan,Ying Zhitao,Zhang Chen,Deng Lijuan,Wang Xiaopei,Song Yuqin,Zhu Jun
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference44 articles.
1. Kohrt H, Advani R. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leuk Lymph. 2009;50(11):1773–84.
2. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19(12):2186–94.
3. Sharma B, Vaziri ND. Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Cancer Res. 1984;44(8):3258–61.
4. Tse E, Kwong YL. How I treat NK/T-cell lymphomas. Blood. 2013;121(25):4997–5005.
5. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24(4):612–8.